The Biologics Effectiveness and Safety (BEST) Initiative is part of the Center for Biologics Evaluation and Research (CBER) surveillance program that aims to fulfill the requirements for the FDA Amendments Act of 2007.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FjV1hTk
No comments:
Post a Comment